|

Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions

RECRUITINGSponsored by California Pacific Medical Center Research Institute
Actively Recruiting
SponsorCalifornia Pacific Medical Center Research Institute
Started2011-07
Est. completion2030-12
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT01750619

Summary

To evaluate clinical outcome for patients receiving treatment of suspected premalignant and malignant gastrointestinal lesions at Interventional Endoscopy Services. The primary outcome is curative endoscopic resection. Secondary outcomes include resection technique utilized, rates of en bloc resection and adverse event rates, including infection, bleeding, perforation and death, and one-year survival rates.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients age \>18 years that have been referred for endoscopic treatment of GI lesions.

Exclusion Criteria:

* Patients for whom endoscopic treatment was not performed.

Conditions3

Benign Neoplasm of Intestinal TractCancerGastrointestinal Neoplasms

Locations1 site

Interventional Endoscopy Services
San Francisco, California, 94115
Jona C BernabeCalitiJ@sutterhealth.org

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.